BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3120436)

  • 1. [Coronary-dilating effect of minimal doses of nitroglycerin].
    Sievert H; Bussmann WD; Selzer G; Kober G; Kaltenbach M
    Z Kardiol; 1987 Oct; 76(10):626-9. PubMed ID: 3120436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-angina and coronary dilating effect of low-dose nitroglycerin].
    Sievert H; Kober G; Schneider W; Kaltenbach M; Bussmann WD
    Z Kardiol; 1989; 78 Suppl 2():48-51; discussion 64-7. PubMed ID: 2511693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary stenosis dilation by low dose intravenous nitroglycerin.
    Sievert H; Selzer G; Schneider W; Kober G; Kaltenbach M; Bussmann WD
    Eur Heart J; 1989 Nov; 10 Suppl F():134-6. PubMed ID: 2515967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose transdermal nitroglycerin therapy: loss of effect within 24 hours?].
    Reiniger G; Kraus F; Dirschinger J; Blasini R; Rudolph W
    Herz; 1985 Jun; 10(3):157-62. PubMed ID: 3926612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical usefulness of high-dose oral nitroglycerin in patients with stable angina pectoris].
    Kośmicki MA; Skorykow-Sapińska A; Sadowski Z
    Wiad Lek; 2003; 56(7-8):313-8. PubMed ID: 14969156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
    Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina.
    Fujita M; Yamanishi K; Miwa K; Inoko M
    Coron Artery Dis; 1994 Jun; 5(6):525-9. PubMed ID: 7952412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-anginal efficacy of oral nitroglycerin. A clinical double-blind study with dose-effect relationships].
    Schneider W; Kaltenbach M; Stahl B; Bussmann WD
    Dtsch Med Wochenschr; 1984 Aug; 109(31-32):1187-91. PubMed ID: 6430666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of coronary heart disease with nitroglycerin patches. Behavior of anti-ischemic effectiveness in continuous administration and following patch free interval].
    Reiniger G; Rudolph W
    Herz; 1985 Oct; 10(5):305-11. PubMed ID: 3934055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Discontinuous drug release as an alternative to interval therapy in the treatment of coronary heart disease with nitroglycerin patches].
    Reiniger G; Rudolph W
    Herz; 1987 Oct; 12(5):348-53. PubMed ID: 3119443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
    Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
    Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitroprusside and nitroglycerin on coronary blood flow in stenotic arteries: study in patients with single-vessel coronary artery disease.
    Gatzov P; Voudris V; Skoularikis J; Gentchev G; Manginas A; Cokkinos DV
    J Invasive Cardiol; 2008 Aug; 20(8):391-5. PubMed ID: 18688061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of buccal nitroglycerin on pulmonary artery pressure at rest and during exercise: a comparison with sublingual nitroglycerin in patients with coronary artery disease.
    Langbehn AF; Sheikhzadeh A; Stierle U; Thoran P
    Z Kardiol; 1983; 72 Suppl 3():239-45. PubMed ID: 6421010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of amlodipine in patients with severe coronary artery disease.
    Navarro Estrada JL; Oliveri R
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S24-8. PubMed ID: 7522284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of oral nitroglycerin in the therapy of exertion angina].
    Ceci V; Longo A; Franchetti-Pardo N; Di Mario F; Milazzotto F; Biffani G
    G Ital Cardiol; 1985 Sep; 15(9):888-896. PubMed ID: 3936739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.